The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
Open accessAbstract
Endocytosis in endothelial cells (ECs) is important for many biomedical applications, including drug delivery by nano- and microscale carriers. However, little is known about how carrier geometry influences endothelial drug targeting, intracellular trafficking, and effects. We studied this using prototype polymer carriers of various sizes (0.1-10 mum) and shapes (spheres versus elliptical disks). Carriers were targeted to intercellular adhesion molecule 1 (ICAM-1), a transmembrane glycoprotein that is upregulated in many pathologies and used as a target for intraendothelial drug delivery. ECs internalized anti-ICAM-coated carriers of up to several microns in size via cell adhesion molecule-mediated endocytosis. This pathway is distinct from caveolar and clathrin endocytosis that operate for submicron-size objects. Carrier geometry was found to influence endothelial targeting in the vasculature, and the rate of endocytosis and lysosomal transport within ECs. Disks had longer half-lives in circulation and higher targeting specificity in mice, whereas spheres were endocytosed more rapidly. Micron-size carriers had prolonged residency in prelysosomal compartments, beneficial for endothelial antioxidant protection by delivered catalase. Submicron carriers trafficked to lysosomes more readily, optimizing effects of acid sphingomyelinase (ASM) enzyme replacement in a model of lysosomal storage disease. Therefore, rational design of carrier geometry will help optimize endothelium-targeted therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
Self-citationMarlin, S. D., & Springer, T. A. (1987) · Cell · doi:10.1016/0092-8674(87)90104-8 · Cited by 1,674
Villanueva, F. S., Jankowski, R. J., Klibanov, S., Pina, M. L., Alber, S. M., Watkins, S. C., Brandenburger, G. H., & Wagner, W. R. (1998) · Circulation · doi:10.1161/01.cir.98.1.1 · Cited by 809
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475
Cited by
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Self-citationBouwmeester, H., Hollman, P. C. H., & Peters, R. J. B. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b01090 · Cited by 1,180
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Self-citationForm Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine
Kinnear, C., Moore, T. L., Rodriguez-Lorenzo, L., Rothen-Rutishauser, B., & Petri-Fink, A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00194 · Cited by 672
Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity
Yu, T., Malugin, A., & Ghandehari, H. (2011) · ACS Nano · doi:10.1021/nn2013904 · Cited by 666
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Kolhar, P., Anselmo, A. C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308345110 · Cited by 646
Self-citationAnselmo, A. C., Zhang, M., Kumar, S., Vogus, D. R., Menegatti, S., Helgeson, M. E., & Mitragotri, S. (2015) · ACS Nano · doi:10.1021/acsnano.5b00147 · Cited by 643
Self-citationHu, X., Hu, J., Tian, J., Ge, Z., Zhang, G., Luo, K., & Liu, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja409686x · Cited by 605
The importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
Nanostructured metal–organic frameworks and their bio-related applications
Giménez-Marqués, M., Hidalgo, T., Serre, C., & Horcajada, P. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.08.008 · Cited by 574
Shaping Cancer Nanomedicine: The Effect of Particle Shape on The In Vivo Journey of Nanoparticles
Toy, R., Peiris, P. M., Ghaghada, K. B., & Karathanasis, E. (2014) · Nanomedicine · doi:10.2217/nnm.13.191 · Cited by 570
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
The effects of polymeric nanostructure shape on drug delivery
Venkataraman, S., Hedrick, J. L., Ong, Z. Y., Yang, C., Ee, P. L. R., Hammond, P. T., & Yang, Y. Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.016 · Cited by 510
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications
Boyer, C., Whittaker, M. R., Bulmus, V., Liu, J., & Davis, T. P. (2010) · NPG Asia Materials · doi:10.1038/asiamat.2010.6 · Cited by 447
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Self-citationAgarwal, R., Singh, V., Jurney, P., Shi, L., Sreenivasan, S. V., & Roy, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305000110 · Cited by 424
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Engineering Nano‐ and Microparticles to Tune Immunity
Moon, J. J., Huang, B., & Irvine, D. J. (2012) · Advanced Materials · doi:10.1002/adma.201200446 · Cited by 404
Li, Y., Kröger, M., & Liu, W. K. (2015) · Nanoscale · doi:10.1039/c5nr02970h · Cited by 376
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
Zahin, N., Anwar, R., Tewari, D., Kabir, M. T., Sajid, A., Mathew, B., Uddin, M. S., Aleya, L., & Abdel-Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05211-0 · Cited by 371
Meng, H., Yang, S., Li, Z., Xia, T., Chen, J., Ji, Z., Zhang, H., Wang, X., Lin, S., Huang, C., et al. (2011) · ACS Nano · doi:10.1021/nn103344k · Cited by 362
The role of nanotechnology in the treatment of viral infections
Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 360
Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355
Self-citationUlusoy, U. (2023) · Minerals · doi:10.3390/min13010091 · Cited by 334
Wang, J., Tian, S., Petros, R. A., Napier, M. E., & DeSimone, J. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1043177 · Cited by 330
Karagoz, B., Esser, L., Duong, H. T., Basuki, J. S., Boyer, C., & Davis, T. P. (2014) · Polym. Chem. · doi:10.1039/c3py01306e · Cited by 328
Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake
Herd, H., Daum, N., Jones, A. T., Huwer, H., Ghandehari, H., & Lehr, C.-M. (2013) · ACS Nano · doi:10.1021/nn304439f · Cited by 326
Macrophages Recognize Size and Shape of Their Targets
Doshi, N., & Mitragotri, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010051 · Cited by 321
Self-citationNanoantioxidants: Recent Trends in Antioxidant Delivery Applications
Khalil, I., Yehye, W. A., Etxeberria, A. E., Alhadi, A. A., Dezfooli, S. M., Julkapli, N. B. M., Basirun, W. J., & Seyfoddin, A. (2019) · Antioxidants · doi:10.3390/antiox9010024 · Cited by 317
Margination of micro- and nano-particles in blood flow and its effect on drug delivery
Müller, K., Fedosov, D. A., & Gompper, G. (2014) · Scientific Reports · doi:10.1038/srep04871 · Cited by 312
Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood
Setyawati, M. I., Tay, C. Y., Docter, D., Stauber, R. H., & Leong, D. T. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00499c · Cited by 308
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Self-citationDoshi, N., Prabhakarpandian, B., Rea-Ramsey, A., Pant, K., Sundaram, S., & Mitragotri, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.007 · Cited by 301
Self-citationThe Shape of Things to Come: Importance of Design in Nanotechnology for Drug Delivery
Liu, Y., Tan, J., Thomas, A., Ou-Yang, D., & Muzykantov, V. R. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.156 · Cited by 299
Self-citationPRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Cooley, M., Sarode, A., Hoore, M., Fedosov, D. A., Mitragotri, S., & Sen Gupta, A. (2018) · Nanoscale · doi:10.1039/c8nr04042g · Cited by 279
Self-citationNano–bio effects: interaction of nanomaterials with cells
Cheng, L.-C., Jiang, X., Wang, J., Chen, C., & Liu, R.-S. (2013) · Nanoscale · doi:10.1039/c3nr34276j · Cited by 276
Polymer particles that switch shape in response to a stimulus
Yoo, J.-W., & Mitragotri, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000346107 · Cited by 275
Self-citationYoo, J.-W., Doshi, N., & Mitragotri, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.004 · Cited by 272
Self-citationEnhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 266
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows
Lee, S.-Y., Ferrari, M., & Decuzzi, P. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/49/495101 · Cited by 257
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Self-citationTashima, T. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00854 · Cited by 120
Ta, H. T., Truong, N. P., Whittaker, A. K., Davis, T. P., & Peter, K. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1316262 · Cited by 105
Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Zheng, C., Zhang, J., Chan, H. F., Hu, H., Lv, S., Na, N., Tao, Y., & Li, M. (2021) · Small Methods · doi:10.1002/smtd.202001191 · Cited by 61
pH-triggered shape response of cubical ultrathin hydrogel capsules
Kozlovskaya, V., Wang, Y., Higgins, W., Chen, J., Chen, Y., & Kharlampieva, E. (2012) · Soft Matter · doi:10.1039/c2sm25641j · Cited by 53
Metadata
- Authors
- Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., Mitragotri, S., & Muzykantov, V. R.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 16
- Issue
- 8
- Pages
- 1450-1458
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2092201159
- Cited by
- 564
- References
- 38
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.